Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CARE Initiative Study: Real-world Emulation of the KEYNOTE-189 Comparative Effectiveness Trial of Pembrolizumab, Pemetrexed, and Chemotherapy vs. Placebo, Pemetrexed, and Chemotherapy for the First-line Treatment of Metastatic Non-small Cell Lung Cancer

NCT06607393 is registered in ClinicalTrials.gov with Aetion, Inc. as lead sponsor.

NCT NCT06607393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06607393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CARE Initiative Study: Real-world Emulation of the KEYNOTE-189 Comparative Effectiveness Trial of Pembrolizumab, Pemetrexed, and Chemotherapy vs. Placebo, Pemetrexed, and Chemotherapy for the First-line Treatment of Metastatic Non-small Cell Lung Cancer
Lead sponsor
Aetion, Inc.
Phase
Observational
Overall status
Completed
Start date
February 1, 2010
Completion date
June 28, 2023
Enrollment
851 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic nonsmall cell lung cancer